Table 3 Associations between clinical characteristics and circulating lncRNAs in patients with well-controlled type 2 diabetes.

From: Circulating long-non coding RNAs as biomarkers of left ventricular diastolic function and remodelling in patients with well-controlled type 2 diabetes

 

LIPCAR

uc004cos.4

uc004cov.4

uc004coz.1

uc011mfi.2

uc022bqu.1

uc022bqw.1

MIAT

SENCR

β

P-value

β

P-value

β

P-value

β

P-value

β

P-value

β

P-value

β

P-value

β

P-value

β

P-value

Age

0.372

0.010*

0.380

0.009*

0.304

0.040*

0.239

0.106

0.184

0.210

0.277

0.060

0.370

0.011*

0.165

0.261

0.162

0.271

Time since diagnosis of diabetes

0.373

0.010*

0.407

0.005*

0.375

0.010*

0.347

0.017*

0.289

0.047*

0.319

0.029*

0.301

0.040*

−0.071

0.633

0.190

0.195

BMI

−0.448

0.002*

−0.380

0.009*

−0.434

0.003*

−0.360

0.013*

−0.416

0.003*

−0.409

0.004*

−0.438

0.002*

−0.161

0.276

0.012

0.934

Waist circumference

−0.459

0.001*

−0.431

0.003*

−0.483

0.001*

−0.429

0.003*

−0.469

0.001*

−0.448

0.002*

-0.458

0.001*

−0.205

0.162

−0.001

0.995

Subcutaneous fat volume

−0.491

<0.001*

−0.416

0.004*

−0.453

0.002*

−0.404

0.005*

−0.462

0.001*

−0.453

0.001*

−0.468

0.001*

−0.168

0.255

−0.024

0.874

Plasma fasting insulin

−0.548

<0.001*

−0.468

0.001*

−0.472

0.001*

−0.441

0.002*

−0.527

<0.001*

−0.475

0.001*

−0.499

<0.001*

−0.165

0.268

0.067

0.654

HDL cholesterol

0.441

0.002*

0.337

0.023*

0.314

0.036*

0.299

0.043*

0.377

0.009*

0.342

0.020*

0.347

0.018*

0.122

0.413

−0.090

0.547

us−CRP

−0.307

0.038*

−0.271

0.071

−0.297

0.048*

−0.245

0.100

−0.317

0.030*

−0.334

0.023*

−0.308

0.037*

−0.148

0.321

−0.031

0.834

  1. *Statistically significant.